Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells

Shantaram S Joshi, U. Eileen Vu, Todd R. Lovgren, Margaret Lorkovic, Wayshalee Patel, Gordon L. Todd, Charles Kuszynski, Bharathi J. Joshi, Harish P. Dave

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Dendritic cells (DC) are important accessory cells that are capable of initiating an immune response. Generation of functional DC has potential clinical use in treating diseases such as cancer. In this report, we have demonstrated the generation of functional DC from mononuclear cells isolated from human umbilical cord blood cells (UCBC) and peripheral blood cells (PBC) using a defined medium Prime Complete Growth Medium™ (PCGM) (GenePrime LLC, Gaithersburg, MD). DC generated using PCGM showed the typical phenotype of DC as determined by flow cytometry and electron microscopy. Further analysis of the DC using confocal microscopy showed localization of the antigen and major histocompatibility complex (MHC) molecules in the cytoplasm 3-5 days following tumor antigen loading into DC. Subsequently, the tumor antigen-MHC complex was localized on the surface of DC. DC generated from UCBC or PBC also increased (p < 0.001) the allogeneic mixed lymphocyte reaction, confirming their immune accessory functions compared to a control mixed lymphocyte reaction (MLR) without DC added. Interestingly, DC generated using PCGM medium also significantly enhanced the hematopoietic colony (CFU-C)-forming ability. Furthermore, addition of 5% DC derived from cord blood loaded with tumor antigen also significantly (p < 0.001) increased peripheral and cord blood-derived antigen-specific cytotoxic T lymphocyte (CTL)-mediated killing of human leukemic cells (K562) and breast cancer cells (MDA-231). Thus, these results show that functional DC generated from cord blood using a defined medium are a useful source of accessory cells for augmenting CTL-mediated cytotoxicity and have potential use in cellular therapy for human leukemia and breast cancer.

Original languageEnglish (US)
Pages (from-to)337-347
Number of pages11
JournalJournal of Hematotherapy and Stem Cell Research
Volume11
Issue number2
DOIs
StatePublished - Apr 25 2002

Fingerprint

Fetal Blood
Dendritic Cells
Blood Cells
Neoplasm Antigens
Mixed Lymphocyte Culture Test
Cytotoxic T-Lymphocytes
Major Histocompatibility Complex
Growth
Breast Neoplasms
Antigens
K562 Cells
Confocal Microscopy
Electron Microscopy
Flow Cytometry
Cytoplasm
Leukemia
Phenotype

ASJC Scopus subject areas

  • Immunology
  • Hematology

Cite this

Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells. / Joshi, Shantaram S; Vu, U. Eileen; Lovgren, Todd R.; Lorkovic, Margaret; Patel, Wayshalee; Todd, Gordon L.; Kuszynski, Charles; Joshi, Bharathi J.; Dave, Harish P.

In: Journal of Hematotherapy and Stem Cell Research, Vol. 11, No. 2, 25.04.2002, p. 337-347.

Research output: Contribution to journalArticle

Joshi, Shantaram S ; Vu, U. Eileen ; Lovgren, Todd R. ; Lorkovic, Margaret ; Patel, Wayshalee ; Todd, Gordon L. ; Kuszynski, Charles ; Joshi, Bharathi J. ; Dave, Harish P. / Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells. In: Journal of Hematotherapy and Stem Cell Research. 2002 ; Vol. 11, No. 2. pp. 337-347.
@article{806f15fc2bc04d32a704f6237856574f,
title = "Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells",
abstract = "Dendritic cells (DC) are important accessory cells that are capable of initiating an immune response. Generation of functional DC has potential clinical use in treating diseases such as cancer. In this report, we have demonstrated the generation of functional DC from mononuclear cells isolated from human umbilical cord blood cells (UCBC) and peripheral blood cells (PBC) using a defined medium Prime Complete Growth Medium™ (PCGM) (GenePrime LLC, Gaithersburg, MD). DC generated using PCGM showed the typical phenotype of DC as determined by flow cytometry and electron microscopy. Further analysis of the DC using confocal microscopy showed localization of the antigen and major histocompatibility complex (MHC) molecules in the cytoplasm 3-5 days following tumor antigen loading into DC. Subsequently, the tumor antigen-MHC complex was localized on the surface of DC. DC generated from UCBC or PBC also increased (p < 0.001) the allogeneic mixed lymphocyte reaction, confirming their immune accessory functions compared to a control mixed lymphocyte reaction (MLR) without DC added. Interestingly, DC generated using PCGM medium also significantly enhanced the hematopoietic colony (CFU-C)-forming ability. Furthermore, addition of 5{\%} DC derived from cord blood loaded with tumor antigen also significantly (p < 0.001) increased peripheral and cord blood-derived antigen-specific cytotoxic T lymphocyte (CTL)-mediated killing of human leukemic cells (K562) and breast cancer cells (MDA-231). Thus, these results show that functional DC generated from cord blood using a defined medium are a useful source of accessory cells for augmenting CTL-mediated cytotoxicity and have potential use in cellular therapy for human leukemia and breast cancer.",
author = "Joshi, {Shantaram S} and Vu, {U. Eileen} and Lovgren, {Todd R.} and Margaret Lorkovic and Wayshalee Patel and Todd, {Gordon L.} and Charles Kuszynski and Joshi, {Bharathi J.} and Dave, {Harish P.}",
year = "2002",
month = "4",
day = "25",
doi = "10.1089/152581602753658529",
language = "English (US)",
volume = "11",
pages = "337--347",
journal = "Stem Cells and Development",
issn = "1547-3287",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

TY - JOUR

T1 - Comparison of phenotypic and functional dendritic cells derived from human umbilical cord blood and peripheral blood mononuclear cells

AU - Joshi, Shantaram S

AU - Vu, U. Eileen

AU - Lovgren, Todd R.

AU - Lorkovic, Margaret

AU - Patel, Wayshalee

AU - Todd, Gordon L.

AU - Kuszynski, Charles

AU - Joshi, Bharathi J.

AU - Dave, Harish P.

PY - 2002/4/25

Y1 - 2002/4/25

N2 - Dendritic cells (DC) are important accessory cells that are capable of initiating an immune response. Generation of functional DC has potential clinical use in treating diseases such as cancer. In this report, we have demonstrated the generation of functional DC from mononuclear cells isolated from human umbilical cord blood cells (UCBC) and peripheral blood cells (PBC) using a defined medium Prime Complete Growth Medium™ (PCGM) (GenePrime LLC, Gaithersburg, MD). DC generated using PCGM showed the typical phenotype of DC as determined by flow cytometry and electron microscopy. Further analysis of the DC using confocal microscopy showed localization of the antigen and major histocompatibility complex (MHC) molecules in the cytoplasm 3-5 days following tumor antigen loading into DC. Subsequently, the tumor antigen-MHC complex was localized on the surface of DC. DC generated from UCBC or PBC also increased (p < 0.001) the allogeneic mixed lymphocyte reaction, confirming their immune accessory functions compared to a control mixed lymphocyte reaction (MLR) without DC added. Interestingly, DC generated using PCGM medium also significantly enhanced the hematopoietic colony (CFU-C)-forming ability. Furthermore, addition of 5% DC derived from cord blood loaded with tumor antigen also significantly (p < 0.001) increased peripheral and cord blood-derived antigen-specific cytotoxic T lymphocyte (CTL)-mediated killing of human leukemic cells (K562) and breast cancer cells (MDA-231). Thus, these results show that functional DC generated from cord blood using a defined medium are a useful source of accessory cells for augmenting CTL-mediated cytotoxicity and have potential use in cellular therapy for human leukemia and breast cancer.

AB - Dendritic cells (DC) are important accessory cells that are capable of initiating an immune response. Generation of functional DC has potential clinical use in treating diseases such as cancer. In this report, we have demonstrated the generation of functional DC from mononuclear cells isolated from human umbilical cord blood cells (UCBC) and peripheral blood cells (PBC) using a defined medium Prime Complete Growth Medium™ (PCGM) (GenePrime LLC, Gaithersburg, MD). DC generated using PCGM showed the typical phenotype of DC as determined by flow cytometry and electron microscopy. Further analysis of the DC using confocal microscopy showed localization of the antigen and major histocompatibility complex (MHC) molecules in the cytoplasm 3-5 days following tumor antigen loading into DC. Subsequently, the tumor antigen-MHC complex was localized on the surface of DC. DC generated from UCBC or PBC also increased (p < 0.001) the allogeneic mixed lymphocyte reaction, confirming their immune accessory functions compared to a control mixed lymphocyte reaction (MLR) without DC added. Interestingly, DC generated using PCGM medium also significantly enhanced the hematopoietic colony (CFU-C)-forming ability. Furthermore, addition of 5% DC derived from cord blood loaded with tumor antigen also significantly (p < 0.001) increased peripheral and cord blood-derived antigen-specific cytotoxic T lymphocyte (CTL)-mediated killing of human leukemic cells (K562) and breast cancer cells (MDA-231). Thus, these results show that functional DC generated from cord blood using a defined medium are a useful source of accessory cells for augmenting CTL-mediated cytotoxicity and have potential use in cellular therapy for human leukemia and breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=0036229649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036229649&partnerID=8YFLogxK

U2 - 10.1089/152581602753658529

DO - 10.1089/152581602753658529

M3 - Article

C2 - 11983105

AN - SCOPUS:0036229649

VL - 11

SP - 337

EP - 347

JO - Stem Cells and Development

JF - Stem Cells and Development

SN - 1547-3287

IS - 2

ER -